C2-HC7 Flashcards

1
Q

What are the 4 phases of natural healing?

A
1 Hemostasis (1h) + 2 inflammation (1d): coagulation, immune cells infiltration, pathogen killing, debris clearance
3 proliferation (1w): fibroblast proliferation, scar formation and wound contraction, collagen synthesis, angiogenesis
4 remodeling (1m-1y): re-epithelialization, ECM remodeling, apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
What are the keyplayers in..
1 homeostasis
2 inflammation
3 angiogenesis
4 remodeling/fibrosos
A

1 Homeostasis: thrombin (important factor in creating blot clots), PDGF-b (growth factor).
2 Inflammation: HIF-1a (it’s the inflammatory process, but also important in the pathway to VEGF).
3 Angiogenesis: FGF-2 (fibroblast growth factor, stimulates fibroblast growth), VEGF (stimulates angiogenesis).
4 Remodelling/fibrosis: TGF-b (important for stimulating the immune response), MMPs (1, 2, 7; metal matrix proteases, which are released easily with the platelet burst).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 pathways of the immune system:

A

myeloid (innate) & lymphoid (adaptive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Properties of the myeloid (innate) pathway:

A

Myeloid; innate
• ‘quick reaction’
• Non-specific: against foreign bodies, injuries and pathogens
• Immediate action
• Physical barriers
• Activated by chemical properties of the antigen
• Bacteria-killing substances
• Protection on the outside: skin
• Protection on the inside: all mucous membranes
First attack in the tissue: scavenger cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Properties of the lymphoid (adaptive) pathway:

A

Lymphoid; adaptive
• ‘slow reaction’
• Antigen-specific: against specific pathogens or changed body cells (virus)
• Processing involved
• Traditionally associated with memory
• Defense cells in the blood: B lymphocytes
• Antibodies
Defense cells in the tissue: T lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the main cells involved in the immune response (order & function)?

A
1 polymorphonuclear neutrophils (PMN):
- phagocytosis
- chemokine production
- short lived
2 macrophages:
- phagocytosis
- cytokine production
- immune modulatory function
3 T lymphocytes
- antigen specific responses
- provide memory
- chronic inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Complements:

A

Complements:
- “Activate all the proteins!”
- Almost all biomaterials used in (orthopaedic) (regenerative) medicine activate the host immune system
- Don’t learn the pathways. Classical and alternative pathways are most used.
- System simplified:
○ Pathway activation depends on stimulus
○ CP: provisional matrix on which IgG binds
○ AP: (wear) debris of biomaterials such as in orthopaedic implants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The complement system is mostly biomaterial-driven;

A

The complement system is mostly biomaterial-driven;

- Activation is triggered by molecules of the initially absorbed protein film. Usually when you implant something a lot of proteins will stick to it due to the charge. 
- Consist of immunoglobulins, fibrinogen and human serum albumin
- Generated C5a and sC5b-9 recruit and activate platelets as well as granulocytes and monocytes
- They bind to the protein-bound iC3b
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Protein film - provisional matrix:

A

Protein film - provisional matrix:

- The provisional matrix is a ECM that secretes proteins. In the beginning it's fibrinogen, usually by platelets when they burst. But due to all these growth factors, other cells are also attracted; fibroblasts, monocytes, macrophages, T-, and B-cells. 
- Fibroblast are important because they produce a lot of ECM, they are the band aid. The collagen is crosslinked and keep things together.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Monocyte subtypes:

Macrphages subtypes:

A

Monocyte subtypes: (don’t know the specifics)

- Classic (CM): (90%) involved with phagocytose and adhesion.
- Intermediate (IM):  (5%) anti-microbial response.
- Non-classical (NCM): (5%) involved in the complement, does phagocytose and migrate.

Monocytes differentiate to macrophage. There are multiple subtypes, which are classified by function. M1 & M2 are most important (pro-inflammatory & anti-inflammatory).

The classifications of macrophages are difficult/ not so rigid as they may seem. It is not black and white (not M1 OR M2, but probably some M1 AND some M2)!
Macrophages are involved in almost everything: Alzheimer’s, COPD, cancer, atherosclerosis, obesity, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T-cells:

A

T-cells:
- Not directly involved
- Different types of T cells: helper cells, regulatory cells
- Collectively, the T lymphocytes play and/or facilitate a central role within the adaptive immune system. Functions:
○ Promotion of inflammation by cytokine production (Th1 and Th17 cells)
○ Helping B lymphocytes (Th2 cells)
○ Regulating immunosuppressive responses (T regulatory cells)
○ Killing of unwanted target cells (CTL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Definition of biocompatibility:

A

Definition of biocompatibility:

  • Appropriate host response (absence of toxicity, chronic inflammation, irritation and/or carcinogenesis)
  • The ability of (bio)materials to perform the specific task for which they are intended
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Stepps of the FBR:

A

Stepps of the FBR:

1. Implantation of a biomaterial
2. Protein (such as albumin and fibrinogen) are absorbed on the surface
3. A few minutes after implantation there are macrophages. They release messengers which serve to initiate the FBR. After a few hours the surface is fully covered with macrophages. During release of the messengers other important cells are also attacked:
	a. Fibroblasts: responsible for the thicker envelopment of the mesh. They form an early scar.
	b. T lymphocytes and polymorphonuclear granular sites.
4. As the process continues, the number of cells increases. After 1 week the early granuloma can be recognized by a typical layering: fibroblasts & ECM. The granuloma now starts to age and there is increased vascularization. 
5. The intensity of stimulus by the macrophages determined the size of the granuloma.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Foreign body giant cell formation (FBGC):

A

Phagocytotic cells find a giant particle and want to eat it, but when this particle is bigger than themselfs they have generate a multinucleated cell and capsulate it. They still excrete the same enzyme, because they want to degrade it. This process is called the Foreign body giant cell formation (FBGC). Thus, the fibroblasts and myofibroblasts encapsulate the material with ECM and cells, so other cells cannot reach it and cannot begin a new immune reaction. So, you end up in a quiet state.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(negative) outcomes of FBR:

A

(negative) outcomes of FBR:
- Unwanted material degradation (because you get these giant cells that secrete a lot of reactive O2 species and proteases).
- Can lead to implant failure
- Implant dysfunction (e.g. Prevents proper interaction material and body such as motorfunction)
- Increased susceptibility to infection (e.g. Dysregulation of neutrophils and macrophages)
- Chronic inflammation
- Pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Prevention of FBR:

A

Prevention of FBR:
- Anti-fouling (e.g. Teflon - material of raincoats): creating a layer that nothing sticks to it.
- Coating with native ECM proteins (the body thinks ‘that is me, that is good’).
- Steering macrophage polarization (you get the macrophage you want - M1 or M2 - and does not disturb the material by adding drugs or peptides).
- Addition of bio-active molecules
Altering surface chemistry

17
Q

Type of cells/ tissues:

A

Type of cells/ tissues:

- Autologous= your own cells
- Syngeneic= twin
- Allogenic= different individual of same species
- Xenogeneic= different species
18
Q

Rejection=

A

Rejection= a process in which a transplant recipient’s immune system attacks the transplanted organ or tissue (these carry antigens on their surface. As soon as these antigens enter the body, the immune system recognizes that they are foreign and attacks them).

19
Q

Types of rejection:

A

host vs graft: hyperacute, acute, chronic

graft vs host

20
Q

Hyperacute rejection:

A

Hyperacute reaction: this is what happens when you have antigens directly on the tissue. E.g., you get a kidney form someone and you are not a match. Your body doesn’t like it to see all these antigens and rejects it within hours. Often the immune system creates thrombin > this leads to platelet activation > recruitment of immune cells > severe reaction > complement activation > clots > immune system activation > thrombosis. Properties:
Ø Clotting of the vascular lumen due to endothelial damage by complement and polymorphonuclear (PMN) cells
○ Pre-formed (donor-specific) antibodies
○ Onset: hours/ days
○ Only in vascularized grafts
○ Leads to vascular thrombosis
○ Through complement activation

You have an antigen your body doesn’t like. You get anti-A/B against the complement system together with CC3a and C5a (neutrophil recruitment). Neutrophils kill the cells because they think ‘these are not my cells’. Endothelial cells are damaged on the graft and in the vasculature, so you get thrombin formation.

21
Q

Acute rejection:

A

Acute rejection:
○ This is done by the major histocompatibility complex (MHC). Mostly for people with cancer stem cell transplantation. Properties:
§ Onset: weeks or months
§ Dependent on B-cells
§ Memory reponse: it takes a bit more for your body to recognize and fight.
○ This happens with the complement which have the damaged associated molecular proteins and the activation of the dendritic cells. They activate the T-cells which leads to a cascade of memories of the adaptive system

22
Q

Chronic rejection:

A

Chronic rejection: all cells are killed by B- and T-cells, but your body still responds to that. You get apoptosis and necrosis and your body still tries to get stuff together. You get all those fibrotic factors in your rejected organ.
- Linked to B- and T-cells with a link to memory function
- Onset: months/ years
Ø A chronic rejection is a controlled formation of specific tissues, but it is not in the way that you want, there is no inhibition.

23
Q

4 types of chronic allograft vasculopathy:

A

Chronic allograft vasculopathy:
A. Intima (endothelial cells on top), media (smooth muscle cells) and adventitia (mostly proteins, small vasculature, keeps everything in place).
B. Chronic rejection: endothelial cells die and can’t inhibit the growth of muscular cells. Over time, you lose intima because there are a lot of big layer cells that grow inward.
C. Constriction: a lot of ECM formation and elastine > constrict your vessel thick layer of endothelial cells.
Vasoconstriction: dysfunctional intima and they grow inward. You don’t get a nice layer formation.

24
Q

How to prevent rejection?

A

How to prevent rejection?

- Create a physical barrier between transplant and donor (semi-) permeable membrane that inhibits cell-cell contact but allows diffusion of oxygen and nutrients (like a tea bag. Factors are still given, but the immune system can not reach it).
- Addition of localized immunomodulatory biomaterials (e.g., you put peptides on there that only attract M2 macrophages).
- Cells with immunosuppressive characteristics such as MSCs.